最終更新日：2025/12/06
The continuous erythropoietin receptor activator significantly reduced the frequency of injections required for patients with anemia due to chronic kidney disease.
正解を見る
The continuous erythropoietin receptor activator significantly reduced the frequency of injections required for patients with anemia due to chronic kidney disease.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
